We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+0.06%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$760M
AUM Growth
-$14.8M
Cap. Flow
-$10.8M
Cap. Flow %
-1.43%
Top 10 Hldgs %
26.66%
Holding
282
New
10
Increased
87
Reduced
123
Closed
24

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.05%
2 Healthcare 13.83%
3 Consumer Staples 13.13%
4 Technology 12.13%
5 Financials 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACTG icon
226
Acacia Research
ACTG
$436M
$251K 0.03%
16,190
EPC icon
227
Edgewell Personal Care
EPC
$1.34B
$249K 0.03%
2,725
NVS icon
228
Novartis
NVS
$292B
$240K 0.03%
2,850
-175
-6% -$14.2K
GLD icon
229
SPDR Gold Trust
GLD
$149B
$239K 0.03%
2,060
-125
-6% -$15.4K
XLE icon
230
State Street Energy Select Sector SPDR ETF
XLE
$41.2B
$239K 0.03%
5,274
+400
+8% +$19.4K
A icon
231
Agilent Technologies
A
$43.4B
$238K 0.03%
5,834
-182
-3% -$7.43K
WOR icon
232
Worthington Enterprises
WOR
$2.8B
$235K 0.03%
10,223
DXCM icon
233
DexCom
DXCM
$34.3B
$230K 0.03%
23,048
AGN
234
DELISTED
Allergan plc
AGN
$229K 0.03%
949
IYC icon
235
iShares US Consumer Discretionary ETF
IYC
$1.2B
$227K 0.03%
7,300
-200
-3% -$6.26K
ACAD icon
236
Acadia Pharmaceuticals
ACAD
$5.02B
$223K 0.03%
9,000
-1,000
-10% -$23.4K
NBL
237
DELISTED
Noble Energy, Inc.
NBL
$222K 0.03%
3,250
WAL icon
238
Western Alliance Bancorporation
WAL
$8.57B
$221K 0.03%
9,246
OREX
239
DELISTED
Orexigen Therapeutics, Inc.
OREX
$220K 0.03%
+5,160
New +$277K
IWD icon
240
iShares Russell 1000 Value ETF
IWD
$84.3B
$219K 0.03%
+2,189
New +$222K
IJK icon
241
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$215K 0.03%
+5,668
New +$220K
KMP
242
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$207K 0.03%
+2,220
New +$198K
AMRC icon
243
Ameresco
AMRC
$1.17B
$186K 0.02%
27,200
-9,000
-25% -$67.9K
INFU icon
244
InfuSystem Holdings
INFU
$240M
$152K 0.02%
48,350
-66,650
-58% -$188K
TNDM icon
245
Tandem Diabetes Care
TNDM
$1.49B
$136K 0.02%
1,014
DYSL
246
DELISTED
Dynasil Corporation of America
DYSL
$120K 0.02%
77,432
ALU
247
DELISTED
Alcatel-Lucent
ALU
$42K 0.01%
+13,832
New +$47.2K
LQMT
248
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
$42K 0.01%
214,500
ELON
249
DELISTED
Echelon Corp
ELON
$41K 0.01%
+2,000
New +$45.1K
AJG icon
250
Arthur J. Gallagher & Co
AJG
$68.6B
-9,355
Closed -$436K

Similar funds

Dowling & Yahnke's Q3 2014 Portfolio in Review

As of Q3 2014, Dowling & Yahnke held 282 positions worth $760M, down 1.9% from $774M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dowling & Yahnke's Q3 2014 filing shows 10 new, 87 increased, 123 reduced and 24 closed positions. Its largest new stake was Tesla: 16,800 shares worth $272K. The largest sale was Intel, an estimated $850K.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dowling & Yahnke's largest Q3 2014 buy was Tesla: 16,800 shares worth $272K.
  • Dowling & Yahnke added most to Qualcomm in Q3 2014, an estimated $540K increase.
  • Dowling & Yahnke's biggest Q3 2014 reduction was Intel, cutting an estimated $850K.
  • Dowling & Yahnke fully exited Air Products & Chemicals in Q3 2014, selling an estimated $536K.
  • Dowling & Yahnke's ten largest holdings make up 27% of its $760M portfolio in Q3 2014.
  • Dowling & Yahnke opened 10 new positions and closed 24 in Q3 2014.
  • Dowling & Yahnke's portfolio value fell 1.9% quarter-over-quarter to $760M.

Based on Dowling & Yahnke's 13F filing for Q3 2014, filed 22 Oct 2014.